Status:
COMPLETED
Prevalence of Oral Side Effects Associated With Chemo and Radiotherapy for Treating Head and Neck Cancer
Lead Sponsor:
Cairo University
Conditions:
Oral Complications of Chemotherapy and Head and Neck Radiation
Eligibility:
All Genders
20-70 years
Brief Summary
A cross-sectional study will be conducted to report oral complications during chemo and radiotherapy treatment in case of patients diagnosed with head and neck cancer and the effect of theses oral sid...
Detailed Description
the primary out come of this study is to report oral side effects associated with chemo and radiotherapy used for treating head and neck cancer .patient will be enrolled and data will be collected fro...
Eligibility Criteria
Inclusion
- Patients after the first week of their treatment till the end of their treatment protocol and at their follow-up visits
- patients who completed ESAS questioner
- Male and female patients from 20 -70 years old who are diagnosed with head and neck cancer.
Exclusion
- Patients who didn't start their treatment before the examination
- Patients who refuse to participate in the study.
- Patients with leukemia or blood cell cancers, infants and children
Key Trial Info
Start Date :
October 2 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 3 2022
Estimated Enrollment :
294 Patients enrolled
Trial Details
Trial ID
NCT04845854
Start Date
October 2 2020
End Date
September 3 2022
Last Update
February 14 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Cancer in Egypt
Cairo, Egypt